Hendrik P N Scholl Selected Research

Retinal Pigments (Pigments, Visual)

9/2021	NEGATIVE VESSEL REMODELING IN STARGARDT DISEASE QUANTIFIED WITH VOLUME-RENDERED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
1/2017	Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness.
1/2015	Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT).
5/2013	Macular telangiectasia type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hendrik P N Scholl Research Topics

Disease

21	Macular Degeneration (Age-Related Maculopathy) 04/2024 - 02/2004
12	Telangiectasis (Telangiectasia) 05/2013 - 01/2007
10	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2024 - 04/2007
9	Stargardt Disease 01/2022 - 07/2007
7	Atrophy 06/2022 - 11/2005
5	Photophobia (Light Sensitivity) 01/2020 - 08/2007
4	Disease Progression 01/2024 - 10/2009
4	Vision Disorders (Hemeralopia) 01/2024 - 01/2019
4	Retinal Degeneration 11/2023 - 12/2016
4	Geographic Atrophy 01/2023 - 08/2009
4	Retinal Detachment (Retinal Detachments) 06/2021 - 01/2019
4	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2020 - 09/2007
4	Retinal Diseases 07/2018 - 12/2003
4	Blindness (Hysterical Blindness) 01/2017 - 07/2008
3	Inflammation (Inflammations) 01/2021 - 10/2011
3	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 10/2011 - 12/2009
2	Ganglion Cysts (Ganglion) 09/2023 - 01/2022
2	Glaucoma 05/2023 - 01/2019
2	Retinal Dystrophies 09/2022 - 01/2019
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 01/2019
2	Epiretinal Membrane (Epiretinal Membranes) 06/2019 - 01/2019
2	Vitelliform Macular Dystrophy 10/2010 - 04/2002
2	Deafness (Deaf Mutism) 04/2007 - 07/2004
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2022
1	North Carolina type 1 retinal Macular dystrophy 01/2022
1	1 Posterior Polymorphous Corneal Dystrophy 01/2022
1	Corneal Neovascularization 01/2021
1	Low Tension Glaucoma 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	COVID-19 01/2021
1	Choroid Diseases 01/2021
1	Fundus Albipunctatus 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Compartment Syndromes 06/2019
1	Retinal Perforations 06/2019
1	Macular Edema 06/2019
1	Proliferative Vitreoretinopathy 04/2019
1	Keratoconus 04/2019
1	Autoimmune Diseases (Autoimmune Disease) 03/2019
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 03/2019
1	Bullous Pemphigoid (Pemphigoid) 03/2019
1	Corneal Diseases (Corneal Disease) 01/2019
1	Cataract (Cataracts) 01/2019
1	Scotoma (Scintillating Scotoma) 01/2017
1	Albinism 01/2016
1	Rare Diseases (Rare Disease) 11/2014

Drug/Important Bio-Agent (IBA)

40	Retinaldehyde (Retinal)IBA 11/2023 - 04/2002
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2010
5	Macular PigmentIBA 01/2016 - 06/2008
4	Complement System Proteins (Complement)IBA 01/2022 - 07/2008
4	Retinal Pigments (Pigments, Visual)IBA 09/2021 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2007
4	Bevacizumab (Avastin)FDA Link 01/2008 - 01/2007
3	TESIBA 01/2022 - 01/2020
3	Complement Factor H (Factor H)IBA 04/2012 - 10/2009
3	Ranibizumab (Lucentis)FDA Link 10/2011 - 09/2010
3	Fluorescein (Funduscein)FDA LinkGeneric 12/2009 - 11/2005
2	LipofuscinIBA 01/2022 - 01/2009
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2019
2	RetinoidsIBA 01/2017 - 12/2003
2	Complement C3 (C3 Complement)IBA 04/2012 - 10/2009
2	Protein Isoforms (Isoforms)IBA 12/2010 - 04/2007
1	GTP Phosphohydrolases (GTPases)IBA 01/2024
1	Oxygen (Dioxygen)IBA 08/2022
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2022
1	Vitamin A (Retinol)FDA LinkGeneric 01/2022
1	5' Untranslated Regions (5' UTR)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	LipocalinsIBA 01/2021
1	GoldIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	2,4- diamino- 5- cyclohexyl- 6- methylpyrimidineIBA 06/2019
1	Silicone OilsIBA 04/2019
1	KalininIBA 03/2019
1	Matrix Metalloproteinases (MMPs)IBA 03/2019
1	Immunoglobulin A (IgA)IBA 03/2019
1	hydroxide ionIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Melanins (Melanin)IBA 01/2016
1	retinol acetateIBA 01/2015
1	lecithin-retinol acyltransferaseIBA 01/2015
1	Fibrillin-2IBA 11/2014
1	Glycoproteins (Glycoprotein)IBA 11/2014
1	ElastinIBA 11/2014
1	LuteinIBA 05/2013
1	ZeaxanthinsIBA 05/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2012

Therapy/Procedure

6	Therapeutics 01/2023 - 09/2010
6	Lasers (Laser) 01/2022 - 07/2007
6	Vitrectomy 06/2021 - 01/2019
3	Corneal Transplantation (Keratoplasty) 01/2022 - 04/2019
2	Plasmapheresis 12/2010 - 05/2009
1	Laser Therapy (Surgery, Laser) 05/2023
1	Transplantation 09/2021
1	Cell Transplantation 01/2021
1	Corneal Cross-Linking 04/2019
1	Refractive Surgical Procedures 01/2019